Creative Medical Technology Holdings, Inc. Increase (Decrease) in Payables to Customers
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Payables to Customers of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPayablesToCustomers · last filed 2022-08-12
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for the quarter ending 2022-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for the quarter ending 2021-12-31 was $337.48K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for the quarter ending 2021-09-30 was -$52.50K, a 577.27% decline year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for fiscal 2021 was $168.78K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for fiscal 2020 was -$490.05K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in payables to customers for fiscal 2019 was -$120.00K.
| Period end | Increase (Decrease) in Payables to Customers 3 month | Increase (Decrease) in Payables to Customers 6 month | Increase (Decrease) in Payables to Customers 9 month | Increase (Decrease) in Payables to Customers 12 month | Increase (Decrease) in Payables to Customers 12 month as first filed |
|---|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $337.48K derived: sum of 3 quarters · filed 2022-08-12 | $284.98K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $337.48K derived: sum of 2 quarters · filed 2022-05-13 | $284.98K derived: sum of 3 quarters · filed 2022-05-13 | $332.48K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-12-31 | $337.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $284.98K derived: sum of 2 quarters · filed 2022-03-30 | $332.48K derived: sum of 3 quarters · filed 2022-08-12 | $168.78K 10-K · filed 2022-03-30 | |
| 2021-09-30 | -$52.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$5.00K derived: sum of 2 quarters · filed 2022-08-12 | -$168.70K 10-Q · filed 2021-11-15 | -$789.95K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-06-30 | $47.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$116.20K 10-Q · filed 2022-08-12 | -$737.45K derived: sum of 3 quarters · filed 2022-08-12 | -$726.45K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$163.70K 10-Q · filed 2022-05-13 | -$784.95K derived: sum of 2 quarters · filed 2022-05-13 | -$773.95K derived: sum of 3 quarters · filed 2022-05-13 | -$703.01K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$621.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$610.25K derived: sum of 2 quarters · filed 2022-03-30 | -$539.31K derived: sum of 3 quarters · filed 2022-03-30 | -$490.05K 10-K · filed 2022-03-30 | $490.05K 10-K · filed 2021-03-17 |
| 2020-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $81.94K derived: sum of 2 quarters · filed 2021-11-15 | $131.20K 10-Q · filed 2021-11-15 | $156.20K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $70.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $120.20K 10-Q · filed 2021-08-16 | $145.20K derived: sum of 3 quarters · filed 2021-08-16 | $80.20K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $49.26K 10-Q · filed 2021-05-17 | $74.26K derived: sum of 2 quarters · filed 2021-05-17 | $9.26K derived: sum of 3 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$40.00K derived: sum of 2 quarters · filed 2021-03-17 | -$120.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$145.00K 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | -$80.00K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |